Cerebrospinal fever, particularity of laboratory diagnosis
pdf

Keywords

cerebrospinal fever,
bacterial meningitis,
laboratory diagnosis.

How to Cite

SAPIR, G. and COJOCARI, D. (2021) “Cerebrospinal fever, particularity of laboratory diagnosis”, One Health & Risk Management , 2(4S), p. 64. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/234 (Accessed: 18June2025).

Abstract

Introduction. Bacterial meningitis (BM) is a medical emergency. BM is the most common and notable infection of the central nervous system, can progress rapidly, and can result in death or permanent debilitation. Not surprisingly, this infection justifiably elicits strong emotional responses and, hopefully, immediate medical intervention. The advent and widespread use of antibacterial agents in the treatment of meningitis have drastically reduced the mortality caused by this disease. The majority of patients with bacterial meningitis survive, but neurological sequelae occur in as many as one-third of all survivors (especially newborns and children). This review is a brief presentation of the pathogenesis of bacterial meningitis and a review of current knowledge, literature, and recommendations on the subject of the laboratory diagnosis of bacterial meningitis.

Material and methods. The objective of the study was to carry out a bibliographic analysis of the literature related particularity of laboratory diagnosis of cerebrospinal fever. The paper analyzes the most relevant publications using Google Academic and Pubmed databases.

Results. Microorganisms encountered in cerebrospinal fluid require rapid and accurate means of detection and identification in the laboratory. Although restricted to morphologic study and Gram reaction, the Gram stain of cerebrospinal fluid has been the primary diagnostic tool for preliminary diagnosis of purulent meningitis, with identification of the etiologic agent often made within one to two hours by direct microscopic examination. Gram stain and appropriate culture procedures still provide the basis for comparing other diagnostic methods. Nonimmunologic methods that show promise in being both rapid and reliable include gas-liquid chromatography and the Limulus amebocyte lysate test. Fatty acid and carbohydrate profiles characteristic of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Staphylococcus aureus in the cerebrospinal fluid of human subjects and animals have been obtained by gas-liquid chromatography. Also, a unique compound has been detected by gas-liquid chromatography in cerebrospinal fluid from patients with tuberculous meningitis. The Limulus test has been reliable in spinal fluid and almost always gives positive results in H. influenzae and other Gram-negative meningitides. Nonspecific test procedures of varying degrees of accuracy and promise include lactic acid, C-reactive protein, and lactate dehydrogenase determination. Direct microscopic examination of cerebrospinal fluid remains the most practical and accurate method for identifying the etiologic basis of bacterial (and fungal) meningitis.

Conclusions. Despite the existence of numerous diagnostic techniques, determining the etiology of infectious meningitis remains difficult and cumbersome in many cases. Delay in diagnosis is a significant contributor to mortality in bacterial meningitis. When evaluating a patient for meningitis, physicians must incorporate many factors to determine the most appropriate tests to order. Physicians must consider local epidemiology, duration of symptoms, current and recent medications, current immune status, country of origin, current living situation, social history, vaccination status and history of travel among other factors. Cutting-edge technologies hold significant promise but require extensive bioinformatics and sample processing expertise.

pdf

|Views: 114| |pdf Downloads: 48|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370